Panel Discussion – Reviewing Efficacy of Administration Routes for Different Therapeutic Modalities Targeting Dry AMD & Geographic Atrophy

Time: 3:45 pm
day: Day Two


  • Is subretinal a viable route for the delivery of therapeutics for dry AMD?
  • Surgical complications associated with intravitreal and subretinal deliveries
  • Moving towards outpatient delivery for better treatment turnover